20 May 2003
Budd-Chiari syndrome – diagnosis and treatment
P. Małkowski, J. Pawlak, B. Michałowicz, R. Pacho, E. Leowska, T. Wróblewski, I. Gorzelak, M. Andrzejewska, J. Szczerbań, B. Górnicka, B. WróblewskaMed Sci Monit 2003; 9(2): 41-47 :: ID: 15317
Abstract
The aim of the paper was to present the authors ’own experience in the field of diagnostics and treatment of Budd-Chiari syndrome.It is a retrospective analysis of 37 cases of Budd-Chiari syndrome treated in the Department since1980.Qualification for treatment was preceded with imaging diagnostics of the lifer and hepatic blood vessels,assessment of hepatic function and hematologic condition of the patients.Ten patients with very advanced disease in the initial period of the analysis were treated symptomatically.In five patients,venous shunts were formed to compensate for the inefficient portal system,three were qualified for intrahepatic portosystemic shunts,six for liver transplantations, one underwent recanalization of the impatent hepatic vein with radiological technique.Twelve patients with incomplete impatency of hepatic veins were treated conservatively.In 7 cases,fibrinolytic treatment for secondary portal thrombosis was instituted.The patients ’age and sex,etiology of the syndrome,clinical course,results of imaging studies and treatment were analyzed.The follow-up time ranged from 2 months to 8 years (mean:34 months). Women with hematologic disorders predominated among the patients.In all the cases,the characteristic symptoms included pain, ascites and hepatosplenomegaly, with additional portal hypertension and hepatic failure at the later stages of the disease. Ultrasonography is an essential diagnostic method used in Budd-Chiari syndrome.Fifteen of the observed patients died,including two cases of postoperative mortality. Budd-Chiari syndrome is a rare pathology of various etiology.The first symptoms include pain,ascites and hepatosplenomegaly. Ultrasonography is an essential diagnostic method.Formation of venous shunts and liver transplantation are effective methods of treatment in selected cases.Polycythemia increases the risk of postoperative complications.Early-onset secondary portal thrombosis provides indication for fibrinolytic treatment
Keywords: Budd-Chiari syndrome, portal thrombosis, thrombolytic treatment
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952